CVC Capital Partners is seeking to withdraw from a nearly €3 billion agreement to acquire the Italian ingredients company Irca from Advent International, a move that could lead to a significant legal confrontation between two major private equity firms.

According to sources familiar with the situation, CVC informed Advent several weeks ago of its intention to pull out of the deal, citing findings from an extensive forensic review of Irca’s financials that rendered the transaction unfeasible. In a statement, CVC said the detailed analysis conducted during due diligence revealed that the deal was no longer viable, and that the decision to exit the agreement was made in accordance with its fiduciary responsibilities to investors and other stakeholders.

Advent International, which acquired Irca in 2022 and initiated a competitive sales process earlier this year, strongly rejected CVC’s withdrawal. The firm characterized the agreement as a binding contract supported by thorough due diligence and affirmed its commitment to taking all necessary legal measures to safeguard its rights and those of Irca and its stakeholders.

The dispute is unusual in the private equity sector, where it is rare for a buyer to attempt to back out after signing a deal. Past instances of deal withdrawals typically occurred due to widely recognized “materially adverse” events, such as the global financial crisis or the COVID-19 pandemic, circumstances that are not cited in this case.

Sources indicate that CVC’s concerns arose after Irca’s business performance reportedly declined following the initial agreement, prompting the forensic review that intensified its reservations about the company’s financial stability. However, Advent contends that there were no contractual provisions or sufficient justifications allowing CVC to withdraw, emphasizing that the deal had been extensively marketed to multiple private equity firms, with CVC selected as the preferred buyer partly because of its ability to expedite the transaction.

Irca specializes in ingredients and semi-finished products for pastry, bakery, chocolate, and ice cream sectors. The company has recently faced challenges linked to rising commodity costs—such as cocoa—and weakening demand, trends that have also affected other industry players like Lindt. The acquisition was originally scheduled to close in the fourth quarter of 2023.

Irca declined to comment on the ongoing dispute. The outcome of this conflict between two prominent firms—Advent, based in Boston, and Amsterdam-listed CVC—could set a precedent in the European private equity landscape, highlighting the complexities and risks involved in aggressive dealmaking amid fluctuating market conditions.